Skip to content
Benefits & EvidenceEvidence-Tiered

5-Amino-1MQ Benefits

What does 5-Amino-1MQ actually do? We break down the evidence by tier — human data, animal studies, and in vitro research — with citations for every claim.

Quick Answer

5-Amino-1MQ's researched benefits include fat cell shrinkage, increased NAD+ levels in adipose tissue, and white-to-beige fat cell conversion. This mechanism works independently of appetite suppression. Its potential lies in treating diet-resistant obesity. Remember, all research is preclinical, and human clinical trials are needed.

→ 5-Amino-1MQ Dosage→ 5-Amino-1MQ Side Effects→ Full 5-Amino-1MQ Profile

Evidence Tiers

HumanClinical or observational human dataAnimalPreclinical in vivo studiesIn VitroCell / tissue culture studies
Table of Contents

Mechanism of Action

5-Amino-1MQ inhibits NNMT, preventing nicotinamide methylation, thereby boosting NAD+ and SAM levels. It promotes white-to-beige fat conversion by upregulating UCP1, enhancing thermogenesis. This is achieved by blocking NNMT, which reduces adipocyte size and adipogenesis without affecting food intake. This mechanism makes it unique among fat loss interventions.

Human Evidence

No completed human trials

No completed randomized controlled trials (RCTs) in humans have been published for 5-Amino-1MQ for the benefits described below. All evidence below is from animal or in vitro research.

Animal Studies

Animal4 findings

Fat cell shrinkage (reduced adipocyte size)

In murine models of obesity, 5-Amino-1MQ reduces adipocyte size, potentially improving insulin sensitivity and metabolic function. It demonstrates promising results in counteracting diet-induced adipocyte hypertrophy.

PubMed 32661032 (2020) ↗

Increased NAD+ levels in adipose tissue

Animal studies demonstrate that 5-Amino-1MQ effectively restores NAD+ levels in fat cells by inhibiting NNMT-mediated nicotinamide degradation. This reactivation supports metabolic pathways essential for fat oxidation.

PubMed 32661032 (2020) ↗

White-to-beige fat cell conversion (browning)

5-Amino-1MQ drives the conversion of white fat cells into beige fat cells, increasing thermogenic energy expenditure. This process upregulates uncoupling protein 1 (UCP1), leading to increased heat production and fat burning.

PubMed 32661032 (2020) ↗

Inhibition of new fat cell formation (adipogenesis)

Preclinical models show that 5-Amino-1MQ inhibits adipogenesis, thus contributing to reduced fat mass. This effect is particularly relevant for long-term weight management. The compound may limit the body's ability to store excess calories as fat.

PubMed 25087974 (2014) ↗

In Vitro Research

In Vitro2 findings
In vitro (cell culture) findings are the earliest stage of evidence. They indicate mechanism plausibility but cannot confirm human effects.

NNMT inhibition in adipocytes

In vitro studies confirm that 5-Amino-1MQ effectively inhibits NNMT in cultured adipocytes. This inhibition leads to a cascade of metabolic changes that promote fat breakdown and energy expenditure.

PubMed 32661032 (2020) ↗

Upregulation of UCP1 expression

Cell culture experiments show that 5-Amino-1MQ increases the expression of UCP1 in white adipocytes, driving the browning process. This confirms a direct effect on adipocyte thermogenesis.

PubMed 32661032 (2020) ↗

What's Proven vs What's Still Unknown

✓ What the Evidence Supports

  • ✓Inhibits NNMT in vitro and in vivo
  • ✓Increases NAD+ levels in adipose tissue in animal models
  • ✓Promotes white-to-beige fat cell conversion in vitro and in vivo
  • ✓Reduces adipocyte size in animal models
  • ✓Inhibits adipogenesis in animal models

? Still Unknown or Unconfirmed

  • ?Effective human therapeutic doses
  • ?Long-term safety profile in humans
  • ?Clinical relevance of metabolic changes observed in animal models
  • ?Optimal administration route and frequency for specific human conditions
  • ?Impact on methylation pathways beyond NNMT inhibition

Frequently Asked Questions

What are the main benefits of 5-Amino-1MQ?
The primary preclinical benefits of 5-Amino-1MQ are fat cell shrinkage, increased NAD+ levels in fat tissue, and conversion of white fat cells to beige fat cells, enhancing thermogenesis. It is being studied for its potential in treating diet-resistant obesity.
How does 5-Amino-1MQ lead to fat loss?
5-Amino-1MQ inhibits NNMT, boosting NAD+ levels in adipocytes and promoting the conversion of white fat to beige fat, which increases energy expenditure. This process reduces fat cell size and hinders new fat cell formation independently of appetite or caloric restriction.
Has 5-Amino-1MQ been tested in human clinical trials?
No, as of early 2026, there are no published, peer-reviewed human clinical trials for 5-Amino-1MQ. The information available is based on animal models. Therefore, the efficacy and safety in humans is not validated.
Can 5-Amino-1MQ improve my metabolic rate?
Preclinical research suggests potential improvements in metabolic rate and insulin sensitivity due to restored NAD+ and SAM pathways. These observations have not been confirmed in human clinical trials. More research is needed to establish these effects.
Is 5-Amino-1MQ better than other fat loss methods?
5-Amino-1MQ utilizes a novel mechanism of fat loss. It works directly on fat cells without suppressing appetite or relying on hormonal changes. In preclinical models, this approach has shown unique promise, but its true value in human fat loss remains unproven and requires further research.

References

  1. 1
    NNMT inhibition effectively activates NAD+ salvage pathway in adipocytes and prevents diet-induced obesity(2020)PubMed ↗
  2. 2
    Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity(2014)PubMed ↗
  3. 3
    Small molecule NNMT inhibitors for the treatment of obesity and metabolic syndrome(2021)PubMed ↗

Last updated: 2026-02-19